Cargando…

Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A -10T genotype

BACKGROUND: Fabry disease (FD) is a multisystemic disorder with typical neurological manifestations such as stroke and small fiber neuropathy (SFN), caused by mutations of the alpha-galactosidase A (GLA) gene. We analyzed 15 patients carrying the GLA haplotype -10C>T [rs2071225], IVS2-81_-77delCA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schelleckes, Michael, Lenders, Malte, Guske, Katrin, Schmitz, Boris, Tanislav, Christian, Ständer, Sonja, Metze, Dieter, Katona, Istvan, Weis, Joachim, Brand, Stefan-Martin, Duning, Thomas, Brand, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255940/ https://www.ncbi.nlm.nih.gov/pubmed/25423912 http://dx.doi.org/10.1186/s13023-014-0178-5

Ejemplares similares

Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene
por: Lenders, Malte, et al.
Publicado: (2013)

Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
por: Lenders, Malte, et al.
Publicado: (2016)

ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA
por: Schelleckes, Katrin, et al.
Publicado: (2018)

Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma
por: Schelleckes, Katrin, et al.
Publicado: (2017)

Dose-Response of High-Intensity Training (HIT) on Atheroprotective miRNA-126 Levels
por: Schmitz, Boris, et al.
Publicado: (2017)

Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease
por: Pogoda, Christian, et al.
Publicado: (2023)

α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes
por: Jehn, Ulrich, et al.
Publicado: (2021)

Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?
por: Lenders, Malte, et al.
Publicado: (2018)

Nonregional small fibre neuropathy in cases of autoimmune autonomic neuropathy
por: Maier, Andrea, et al.
Publicado: (2022)

Fabry disease – a multisystemic disease with gastrointestinal manifestations
por: Lenders, Malte, et al.
Publicado: (2022)

Fabry Disease: The Current Treatment Landscape
por: Lenders, Malte, et al.
Publicado: (2021)

Mechanisms of Neutralizing Anti-drug Antibody Formation and Clinical Relevance on Therapeutic Efficacy of Enzyme Replacement Therapies in Fabry Disease
por: Lenders, Malte, et al.
Publicado: (2021)

Assessment and impact of dose escalation on anti-drug antibodies in Fabry disease
por: Lenders, Malte, et al.
Publicado: (2022)

Case Report: A Spinal Ischemic Lesion in a 24-Year-Old Patient With Fabry Disease
por: Krämer, Julia, et al.
Publicado: (2020)

Uncommon Female-Predominant Etiologies of Cryptogenic Stroke
por: Dong, Jing, et al.
Publicado: (2022)

In Vitro and In Vivo Amenability to Migalastat in Fabry Disease
por: Lenders, Malte, et al.
Publicado: (2020)

Characterization of pre-existing anti-PEG and anti-AGAL antibodies towards PRX-102 in patients with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2023)

Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease
por: van der Veen, Sanne J., et al.
Publicado: (2020)

Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice
por: Nouh, Amre, et al.
Publicado: (2016)

Can Hepatitis E Virus Be Considered as an Etiology of Cryptogenic Cirrhosis?
por: Sohrabi, Masoudreza, et al.
Publicado: (2014)

Pre-existing anti-drug antibodies in Fabry disease show less affinity for pegunigalsidase alfa
por: Lenders, Malte, et al.
Publicado: (2022)

Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale
por: Tanislav, Christian, et al.
Publicado: (2010)

Longer Work/Rest Intervals During High-Intensity Interval Training (HIIT) Lead to Elevated Levels of miR-222 and miR-29c
por: Schmitz, Boris, et al.
Publicado: (2018)

Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation
por: Pollmann, Solvey, et al.
Publicado: (2021)

Armoured brain of unknown etiology
por: Goyal, Puneet Kumar, et al.
Publicado: (2013)

Bloodstained sputum of unknown etiology
por: Fernandes, Filipa, et al.
Publicado: (2017)

Chronic Pruritus of Unknown Origin: Clinical Profile and Disease-Related Burden
por: PEREIRA, Manuel P., et al.
Publicado: (2021)

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2016)

Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

May-Thurner Syndrome and Patent Foramen Ovale: A Rare Etiology of Cryptogenic Stroke
por: Phelps, Benjamin J, et al.
Publicado: (2019)

Factors associated with shunt dynamic in patients with cryptogenic stroke and patent foramen ovale: an observational cohort study
por: Tanislav, Christian, et al.
Publicado: (2011)

Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease
por: Schmitz, Boris, et al.
Publicado: (2019)

Characteristics of mutational signatures of unknown etiology
por: Hu, Xiaoju, et al.
Publicado: (2020)

Hepatitis of an Unknown Etiology with Concomitant ITP
por: Tagliaferri, Ariana, et al.
Publicado: (2023)

Yield of upper gastrointestinal screening in colonic adenomatous polyposis of unknown etiology: a multicenter study
por: Farah, Filsan, et al.
Publicado: (2022)

On the etiology of tropical epidemic neuropathies.
por: de la Fuente, J, et al.
Publicado: (1999)

Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines
por: McMahon, Naoimh E., et al.
Publicado: (2020)

Evaluating the Potential Pathology and Short-Term Outcomes of Cryptogenic Stroke Using the Etiological Classification System
por: Shimizu, Takahiro, et al.
Publicado: (2023)

Generation and Characterization of a Polyclonal Human Reference Antibody to Measure Anti-Drug Antibody Titers in Patients with Fabry Disease
por: Lenders, Malte, et al.
Publicado: (2021)

The Incidence of Primary Atypical Pneumonia of Unknown Etiology
por: Gallagher, J. Roswell
Publicado: (1948)

Cannot write session to /tmp/vufind_sessions/sess_gbajlfppuong9ac83m8ehhpu44